Elevated Levels of Circulating Intercellular Adhesion Molecule-3 (clCAM-3) in Psoriasis

Acta Dermato-Venereologica

Volumn 76, Issue 1, 1996, Pages 2-5

  Griffiths, Christopher E M ^a   Boffa, Michael J ^a   Gallatin, W Michael ^b   Martin, Stephan ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

cICAM 1; cTNF receptor; Psoriasis severity

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL ADHESION MOLECULES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES;

EID: 0029876338     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. de Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 1994; 179: 619-629.
2. Fawcett J, Holness CLL, Needham LA, Turley H, Gatter KC, Mason DY, et al. Molecular cloning of ICAM-3 a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992; 360: 481-484.
3. Martin S, Rieckmann P, Melchers I, Wagner R, Bertrams J, Voskuyl AE, et al. Circulating forms of ICAM-3 (cICAM-3): elevated levels in autoimmune diseases and lack of association with ICAM-1. J Immunol 1995; 154: 1951-1955.
4. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
5. de Fougerolles AR, Springer TA. Intercellular adhesion molecule-3, a third adhesion counter receptor for lymphcoyte function associated antigen-1 on resting lymphocytes. J Exp Med 1992; 175: 185-190.
6. Acevedo A, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Gonzalez-Amara R, Sanchez-Madrid F. Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter receptor for LFA-1 in epidermal Langerhans cells. Am J Pathol 1993; 143: 774-783.
7. + T-cells. Br J Dermatol 1995, in press.
8. Singer KH, Tuck DT, Sampson HA, Hall RP. Epidermal keratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses. J Invest Dermatol 1989; 92: 746-750.
9. Griffiths CEM, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin : modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989; 20: 617-629.
10. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon γ and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med 1988; 167: 1323-1340.
11. Nickoloff BJ, Griffiths CEM. T lymphocytes and monocytes bind to keratinocytes in frozen sections of normal skin treated with gamma interferon. J Am Acad Dermatol 1989; 20: 736-743.
12. Griffiths CEM. Cutaneous leukocyte trafficking and psoriasis. Arch Dermatol 1994; 130: 494-498.
13. Schopf RE, Naumann S, Rehder M, Morsches B. Soluble intercellular adhesion molecule-1 levels in patients with psoriasis. Br J Dermatol 1993; 128: 34-37.
14. Kowalzick L, Bildau H, Neuber K, Köhler I, Ring J. Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels. Arch Dermatol Res 1993; 185: 233-235.
15. Groves RW, Kapahi P, Barker JNWN, Haskard DO, MacDonald DM. Detection of circulating adhesion molecules in erythrodermic skin disease. J Acad Dermatol 1995; 33: 32-36.
16. Kowalzick L, Kleinheinz A, Neuber K, Weichenthal M, Köhler I, Ring J. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment. Dermatology 1995; 190: 14-18.
17. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991; 173: 673-679.
18. Loetscher H, Pan Y-C E, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, et al. Molecular cloning and expression of the human 55kd tumor necrosis factor receptor. Cell 1990; 61: 351-359.
19. Brockhaus, M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two kinds of TNF receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127-3131.
20. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM. Localization of tumour necrosis factor - alpha (TNF-α) and its receptors in normal and psoriatic skin : epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 1993; 94: 354-362.
21. Mohler KM, Torrance DS, Smith CA Goodwin RG, Stremler KE, Fung KP, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 151: 1548-156.
22. Nickoloff BJ, Karabin GD, Barker JNWN, Griffiths CEM, Sarma V, Mitra RS, et al. Cellular localization of IL-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 1991; 138: 129-140.
23. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RDR. Elevated tumour necrosis factor α (TNF-α) biological activity in psoriatic skin lesions. Clin Exp Immunol 1994; 96: 146-151.
24. Kowalzick L, Neuber K, Weichenthal M, Köhler I, Ring J. Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis. Arch Dermatol Res 1994; 186: 414-416.
25. Fredriksson T, Petersson V. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
26. Gearing AJH, Newmann W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
27. Rieckmann P, Martin S, Weichselbraun I, Albrecht M, Kitze B, Weber T, et al. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 1994; 44: 2367-2372.
28. Langkopf F, Atzpodien J. Soluble tumour necrosis factor receptors as prognostic factors in cancer patients. Lancet 1994; 344: 57-58.
29. Roep BO, Heidenthal E, de Vries RRP, Kolb H, Martin S. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 1994; 343: 1590-1593.